| © 2026 Freed Associates, Inc. 28 Gene therapy, biologics, and specialty pharmaceuticals are redefining treatment possibilities from cell-based cancer therapies to GLP-1 drugs advancing obesity care. These innovations are blurring the lines between acute and chronic disease management while raising new ethical and financial questions about equitable access and cost. Those that proactively integrate innovation with affordability and patient access will turn scientific breakthroughs into sustainable care delivery. Breakthrough Therapies and Biologics Are Expanding Medicine’s Frontiers. California’s leadership in biotech and life sciences ensures that new therapies move from discovery to delivery faster, positioning the state as both an innovation hub and a proving ground for the next generation of precision medicine. The broader biotechnology market* is projected to expand from about $478.5 billion in 2024 to roughly $1.78 trillion by 2034 *Including personalized medicine, gene editing, etc. CONTACT AN EXPERT California Trends
RkJQdWJsaXNoZXIy MzY4MjIw